Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Effect of Glucagon-Like Peptide 2 on Hepatic, Renal, and Intestinal Disposition of 1-Chloro-2,4-dinitrobenzene

Silvina S. M. Villanueva, Virginia G. Perdomo, María L. Ruiz, Juan P. Rigalli, Agostina Arias, Marcelo G. Luquita, Mary Vore, Viviana A. Catania and Aldo D. Mottino
Drug Metabolism and Disposition July 2012, 40 (7) 1252-1258; DOI: https://doi.org/10.1124/dmd.111.044339
Silvina S. M. Villanueva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia G. Perdomo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María L. Ruiz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan P. Rigalli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agostina Arias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo G. Luquita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Vore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viviana A. Catania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aldo D. Mottino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 40 no. 7 1252-1258
DOI 
https://doi.org/10.1124/dmd.111.044339
PubMed 
22453052

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 16, 2011
  • Accepted March 27, 2012
  • Published online June 20, 2012.

Article Versions

  • Earlier version (March 27, 2012 - 11:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Silvina S. M. Villanueva,
  2. Virginia G. Perdomo,
  3. María L. Ruiz,
  4. Juan P. Rigalli,
  5. Agostina Arias,
  6. Marcelo G. Luquita,
  7. Mary Vore,
  8. Viviana A. Catania and
  9. Aldo D. Mottino
  1. Instituto de Fisiología Experimental (Consejo Nacional de Investigaciones Científicas y Técnicas)-Facultad de Ciencias Bioquímicas y Farmacéuticas (Universidad Nacional de Rosario), Rosario, Argentina (S.S.M.V., V.G.P., M.L.R., J.P.R., A.A., M.G.L., V.A.C., A.D.M.); and Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky (M.V.)
  1. Address correspondence to:
    Dr. Aldo D. Mottino, Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Suipacha 570, S2002LRL Rosario, Argentina. E-mail: amottino{at}unr.edu.ar
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2012 to January 2021

AbstractFullPdf
Mar 2012179129
Apr 2012266062
May 2012100123
Jun 2012691631
Jul 20127201322
Aug 2012147513
Sep 201210926
Oct 201283612
Nov 20126244
Dec 20125407
Jan 201311113
Feb 20136385
Mar 20134924
Apr 20134324
May 20134637
Jun 20133104
Jul 20132633
Aug 20131345
Sep 20134753
Oct 20134342
Nov 201318154
Dec 201323616
Jan 201418125
Feb 20142455
Mar 20141426
Apr 20141368
May 201422718
Jun 20142586
Jul 20143285
Aug 20142362
Sep 20141098
Oct 20142453
Nov 2014241010
Dec 20142193
Jan 20151561
Feb 20151634
Mar 201522101
Apr 20151644
May 20151242
Jun 20152291
Jul 2015111312
Aug 20151466
Sep 20151866
Oct 20152332
Nov 20152033
Dec 20152865
Jan 201616510
Feb 2016777
Mar 2016848
Apr 2016161212
May 201619127
Jun 20161796
Jul 20161652
Aug 20162366
Sep 20168142
Oct 20164628
Nov 20162163
Dec 20163104
Jan 20170226
Feb 20170154
Mar 20170301
Apr 20170240
May 20170178
Jun 20171163
Jul 20172204
Aug 201712310
Sep 20174106
Oct 20171109
Nov 201752212
Dec 20175194
Jan 20183238
Feb 20180122
Mar 20181128
Apr 20181179
May 20182111
Jun 20180116
Jul 20181163
Aug 20180159
Sep 20180149
Oct 20180114
Nov 2018082
Dec 2018512
Jan 2019200
Feb 2019901
Mar 2019902
Apr 20191103
May 20191102
Jun 2019205
Jul 2019902
Aug 20191201
Sep 20191401
Oct 2019820
Nov 20192010
Dec 20191602
Jan 20201100
Feb 20201400
Mar 20201100
Apr 2020802
May 2020621
Jun 20201300
Jul 2020711
Aug 2020603
Sep 20201401
Oct 20201602
Nov 2020902
Dec 2020901
Jan 2021131

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (7)
Drug Metabolism and Disposition
Vol. 40, Issue 7
1 Jul 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Glucagon-Like Peptide 2 on Hepatic, Renal, and Intestinal Disposition of 1-Chloro-2,4-dinitrobenzene
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

EFFECT OF GLP-2 ON CDNB DISPOSITION

Silvina S. M. Villanueva, Virginia G. Perdomo, María L. Ruiz, Juan P. Rigalli, Agostina Arias, Marcelo G. Luquita, Mary Vore, Viviana A. Catania and Aldo D. Mottino
Drug Metabolism and Disposition July 1, 2012, 40 (7) 1252-1258; DOI: https://doi.org/10.1124/dmd.111.044339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationShort Communication

EFFECT OF GLP-2 ON CDNB DISPOSITION

Silvina S. M. Villanueva, Virginia G. Perdomo, María L. Ruiz, Juan P. Rigalli, Agostina Arias, Marcelo G. Luquita, Mary Vore, Viviana A. Catania and Aldo D. Mottino
Drug Metabolism and Disposition July 1, 2012, 40 (7) 1252-1258; DOI: https://doi.org/10.1124/dmd.111.044339
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more SHORT COMMUNICATIONS

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics